Ocular Therapeutix, Inc.Ocular Therapeutix, Inc.Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc.

No trades
See on Supercharts
Market capitalization
‪775.84 M‬USD
−1.01USD
‪−80.74 M‬USD
‪58.44 M‬USD
‪135.05 M‬
Beta (1Y)
2.55

About Ocular Therapeutix, Inc.

CEO
Pravin U. Dugel
Headquarters
Bedford
Website
Employees (FY)
267
Founded
2006
ISIN
US67576A1007
FIGI
BBG001J1BZV0
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OCUL is 5.22 USD — it has decreased by 10.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ocular Therapeutix, Inc. stocks are traded under the ticker OCUL.
Ocular Therapeutix, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
OCUL stock is 18.47% volatile and has beta coefficient of 2.55. Check out the list of the most volatile stocks — is Ocular Therapeutix, Inc. there?
One year price forecast for Ocular Therapeutix, Inc. has a max estimate of 24.00 USD and a min estimate of 11.00 USD.
OCUL earnings for the last quarter are −0.01 USD per share, whereas the estimation was −0.29 USD resulting in a 97.89% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about Ocular Therapeutix, Inc. earnings.
Ocular Therapeutix, Inc. revenue for the last quarter amounts to ‪15.08 M‬ USD despite the estimated figure of ‪15.23 M‬ USD. In the next quarter revenue is expected to reach ‪15.70 M‬ USD.
Yes, you can track Ocular Therapeutix, Inc. financials in yearly and quarterly reports right on TradingView.
OCUL stock has fallen by 36.73% compared to the previous week, the month change is a 46.46% fall, over the last year Ocular Therapeutix, Inc. has showed a 9.53% decrease.
OCUL net income for the last quarter is ‪−29.22 M‬ USD, while the quarter before that showed ‪−516.00 K‬ USD of net income which accounts for ‪−5.56 K‬% change. Track more Ocular Therapeutix, Inc. financial stats to get the full picture.
Today Ocular Therapeutix, Inc. has the market capitalization of ‪775.83 M‬, it has decreased by 5.78% over the last week.
No, OCUL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OCUL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ocular Therapeutix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
OCUL reached its all-time high on Mar 25, 2015 with the price of 44.19 USD, and its all-time low was 2.00 USD and was reached on Nov 10, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 22, 2024, the company has 267.00 employees. See our rating of the largest employees — is Ocular Therapeutix, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ocular Therapeutix, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ocular Therapeutix, Inc. stock shows the sell signal. See more of Ocular Therapeutix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Ocular Therapeutix, Inc. future price: according to them, OCUL price has a max estimate of 24.00 USD and a min estimate of 11.00 USD. Read a more detailed Ocular Therapeutix, Inc. forecast: see what analysts think of Ocular Therapeutix, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ocular Therapeutix, Inc. EBITDA is ‪−79.40 M‬ USD, and current EBITDA margin is −135.86%. See more stats in Ocular Therapeutix, Inc. financial statements.